skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Balancing false discovery and false negative rates in selection of differentially expressed genes in microarrays

Methodology

(1991) Views  (470) Full article downloads

Authors: Byung S Park, Motomi Mori

Published Date February 2010 Volume 2010:2 Pages 1 - 9
DOI: http://dx.doi.org/10.2147/OAB.S7181

Byung S Park1,2,3, Motomi Mori1,2,3

1Division of Biostatistics, Department of Public Health and Preventive Medicine, 2Biostatistics Shared Resource, Knight Cancer Institute, 3Biostatistics and Design Program, Oregon Clinical and Translational Science Institute, Oregon Health and Science University, Portland, OR, USA

Abstract: Genome-wide mRNA expression profiling using microarrays is widely available today, yet analysis and interpretation of the resulting high dimensional data continue to be a challenge for biomedical scientists. In a typical microarray experiment, the number of biological samples is quite modest compared with the number of genes on a microarray, and a probability of falsely declaring differential expression is unacceptably high without any adjustment for multiple comparisons. However, a stringent multiple comparison procedure can lead to an unacceptably high false negative rate, potentially missing a large fraction of truly differentially expressed genes. In this paper we propose a new “balancing factor score” (BFS) method for identifying a set of differentially expressed genes. The BFS method combines a traditional P value criterion with any other informative factors (referred to as balancing factors) that may help to identify differentially expressed genes. We evaluate the performance of the BFS method when the observed fold change is used as a balancing factor in a simulation study and show that the BFS method can substantially reduce the false negative rate while maintaining a reasonable false discovery rate.

Keywords: balancing factor score method, microarrays, multiple comparisons, false discovery rate, false negative rate








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden
Refinement of rigid-body protein–protein docking using backbone and side-chain minimization with a coarse-grained model
Computational methods for the identification of microRNA targets
Assessing 3D scores for protein structure fragment mining
The interpretation of protein structures based on graph theory and contact map
Errantum: Treatment of human astrocytoma U87 cells with silicon dioxide nanoparticles lowers their survival and alters their expression of mitochondrial and cell signaling proteins
Editorial
Evolution of visual performance in 70 eyes implanted with the Tecnis® ZMB00 multifocal intraocular lens